Phagocytic cell dysfunction.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D001803:Blood Transfusion; D002448:Cell Adhesion; D002633:Chemotaxis; D005260:Female; D006098:Granulocytes / Q000473:pathology / Q000503:physiopathology / Q000637:transplantation; D006105:Granulomatous Disease, Chronic / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006942:Hypergammaglobulinemia / Q000276:immunology / Q000503:physiopathology; D007073:Immunoglobulin E / Q000032:analysis; D008163:Luminescent Measurements; D009504:Neutrophils / Q000276:immunology; D010585:Phagocyte Bactericidal Dysfunction / Q000097:blood / Q000276:immunology*; D010586:Phagocytes / Q000473:pathology / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D007073:Immunoglobulin E; D001205:Ascorbic Acid